Cash Flow from Operating Activities: A company's cash flows from operations.
Enveric Biosciences, Inc. (ENVB) had Cash Flow from Operating Activities of $-2.39M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.19M |
|
-- |
|
-- |
|
$2.19M |
|
$-2.19M |
|
$0.00M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.11M |
|
1.80M |
|
1.80M |
|
$-1.22 |
|
$-1.22 |
|
| Balance Sheet Financials | |
$4.83M |
|
$0.27M |
|
$0.27M |
|
$5.10M |
|
$1.18M |
|
-- |
|
-- |
|
$1.18M |
|
$3.92M |
|
$3.92M |
|
$3.92M |
|
2.47M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-2.39M |
-- |
|
$4.45M |
|
$2.24M |
|
$4.29M |
|
$2.05M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-55.77% |
|
-55.77% |
|
-42.82% |
|
-55.77% |
|
$1.58 |
|
$-1.33 |
|
$-1.33 |
|